Perkin Elmer Genetic Screening Processor (GSP) Product Code: 2021-0010 Product Usage: The GS...

FDA Device Recall #Z-2121-2012 — Class II — June 27, 2012

Recall Summary

Recall Number Z-2121-2012
Classification Class II — Moderate risk
Date Initiated June 27, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Perkinelmer
Location Waltham, MA
Product Type Devices
Quantity 78 units

Product Description

Perkin Elmer Genetic Screening Processor (GSP) Product Code: 2021-0010 Product Usage: The GSP instrument is a fully automated, high throughput batch analyzer for time- resolved and prompt fluorescence analysis of samples in microtitration plates. It is intended for in vitro quantitative / qualitative determination of analytes in body fluids. The reagent kits running on the GSP instrument are used to test blood specimens dried on filter paper as an aid in screening newborns for congenital disorders. Currently assays for the determination of T4, TSH, 17OHP, IRT and GALT are cleared and available for use with the GSP instrument.

Reason for Recall

Contamination from GSP Shaker unit results in decreased signal activity of assay measurements for Genetic Screening for Neonatal IRT, TSH and IRT

Distribution Pattern

Worldwide Distribution - US (nationwide) and the countries of Australia, Belgium, Brazil, Egypt, France, Germany, Netherlands, Norway, Saudi Arabia,Switzerland,

Lot / Code Information

Serial Numbers: 20210001 through 20210078

Other Recalls from Perkinelmer

Recall # Classification Product Date
Z-0632-2016 Class II Perkin Elmer WIZARD2 1-detector, 550 samples Pr... Dec 8, 2015
Z-0638-2016 Class II Perkin Elmer WIZARD2 1-detector,3", 1000 sample... Dec 8, 2015
Z-0634-2016 Class II Perkin Elmer ClWIZARD2 5-detector, 550 samples ... Dec 8, 2015
Z-0636-2016 Class II Perkin Elmer WIZARD2 5-detector, 1000 samples ... Dec 8, 2015
Z-0635-2016 Class II Perkin Elmer WIZARD2 10-detector, 550 samples P... Dec 8, 2015

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.